Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist.
In this article we will review the role of long acting beta2-adrenoreceptor agonists and long-acting muscarinic agents in the management of airflow obstruction. We will then focus our attention on indacaterol, one of the new once daily inhaled beta2-adrenoreceptor agonists. Pharmacologically this drug is a nearly full beta2-agonist without loss of efficacy after prolonged administration. We will also discuss its dosing, safety and tolerability.
Roig
Jorge
J
Servei de Pneumologia, Hospital Nostra Senyora de Meritxell, Escaldes, Andorra, Spain.
Hernando
Rosana
R
Mora
Ramon
R